Elevation Pharmaceuticals Receives $30,000,000 Series A Funding

  • Feed Type
  • Date
    1/21/2010
  • Company Name
    Elevation Pharmaceuticals
  • Mailing Address
    12671 High Bluff Drive San Diego, CA 92130
  • Company Description
    Founded in 2008, Elevation Pharmaceuticals is developing a pipeline of improved aerosol drug products for COPD patients. Our founding team has a successful track record starting companies and building dedicated teams to develop new drug products that improve patients’ lives. At Elevation, we have a disciplined approach to strategic decision-making that helps us stay focused on the path with the highest probability of success. We are executing our drug development plans with passion, integrity, and a high sense of urgency in order to meet the needs and expectations of our stakeholders — employees, investors, partners, and patients.
  • Website
    http://www.elevationpharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $30,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    This capital will enable development of our first candidate through mid-stage clinical trials as well as begin development of a pipeline of product candidates targeted at underserved patient subpopulations with respiratory disease.
  • M&A Terms
  • Venture Investor
    Canaan Partners
  • Venture Investor
    TPG – Texas Pacific Group Ventures
  • Venture Investor
    Care Capital
  • Venture Investor
    Mesa Verde Venture Partners

By posting a comment, you agree to our terms and conditions.